US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation

Jul 22, 2025 - 07:00
 0  0
US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation
London, UK 17 July 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0